Pembrolizumab‐induced pancytopenia in a patient with squamous cell lung cancer
Pembrolizumab‐induced pancytopenia in a patient with squamous cell lung cancer
About this item
Full title
Author / Creator
Ueki, Yuriko , Suzuki, Manabu , Horikawa, Yuriko , Watanabe, Hiromu , Yamaguchi, Yoh , Morita, Chie , Tsukada, Akinari , Takumida, Hiroshi , Kusaba, Yusaku , Katsuno, Takashi , Tsujimoto, Yoshie , Sakamoto, Keita , Hashimoto, Masao , Terada, Junko , Ishii, Satoru , Takasaki, Jin , Naka, Go , Iikura, Motoyasu , Izumi, Shinyu , Takeda, Yuichiro , Hojo, Masayuki and Sugiyama, Haruhito
Publisher
Melbourne: John Wiley & Sons Australia, Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Melbourne: John Wiley & Sons Australia, Ltd
Subjects
More information
Scope and Contents
Contents
Immune checkpoint inhibitors (ICIs) are reportedly effective against many kinds of neoplasm, but may be responsible for several kinds of immune‐related adverse events (irAEs). Among these irAEs, the incidence of myelosuppression due to ICIs is relatively low. Corticosteroids are needed to control most cases of myelosuppression. Here, we report an 8...
Alternative Titles
Full title
Pembrolizumab‐induced pancytopenia in a patient with squamous cell lung cancer
Authors, Artists and Contributors
Author / Creator
Suzuki, Manabu
Horikawa, Yuriko
Watanabe, Hiromu
Yamaguchi, Yoh
Morita, Chie
Tsukada, Akinari
Takumida, Hiroshi
Kusaba, Yusaku
Katsuno, Takashi
Tsujimoto, Yoshie
Sakamoto, Keita
Hashimoto, Masao
Terada, Junko
Ishii, Satoru
Takasaki, Jin
Naka, Go
Iikura, Motoyasu
Izumi, Shinyu
Takeda, Yuichiro
Hojo, Masayuki
Sugiyama, Haruhito
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_25dedb817d3148c69a374d619a8d248d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_25dedb817d3148c69a374d619a8d248d
Other Identifiers
ISSN
1759-7706
E-ISSN
1759-7714
DOI
10.1111/1759-7714.13582
